FindTrial
Sign In

Role of fetal myocardial performance index in evaluation of fetal growth restriction

Clinical application of fetal myocardial performance index in evaluation of fetal growth restriction - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2026/02/104856
Enrollment
74
Registered
2026-02-26
Start date
Unknown
Completion date
Unknown
Last updated
2026-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O00-O9A- Pregnancy, childbirth and the puerperium Health Condition 2: O94- Sequelae of complication of pregnancy, childbirth, and the puerperium

Interventions

Intervention1: Nil: Nil Intervention2: Nil: Nil

Sponsors

Dr Sanchita Narayanan
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Diagnosed cases of fetal growth restriction on the basis of antenatal scans

Exclusion criteria

Exclusion criteria: Fetus with structural or chromosomal anomaly

Design outcomes

Primary

MeasureTime frame
Assessment of fetal cardiac dysfunction using myocardial performance index in fetuses with IUGRTimepoint: Single measurement when IUGR is first diagnosed—

Secondary

MeasureTime frame
Correlation between myocardial performance index values & perinatal outcomesTimepoint: at recruitment & subsequent follow ups—

Countries

India

Contacts

Public ContactDr Sanchita Narayanan
Shripad.hebbar@manipal.edu9611786463

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Mar 14, 2026